新聞稿

Varian Reports Results for Third Quarter of Fiscal Year 2020

Third Quarter 2020 Summary

Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction

/PRNewswire/ -- Varian (NYSE: VAR) today announced that it has entered into a definitive agreement to combine with Siemens Healthineers AG (Frankfurt: SHL) in an all-cash transaction valued at $16.4 billion on a fully diluted basis.

Varian Announces Third Quarter Fiscal Year 2020 Earnings Release Date

Varian (NYSE: VAR) today announced its third quarter fiscal year 2020 earnings release date. The Company will report results for the third quarter of fiscal year 2020 after market close on...

部落格文章

HyperArc Proves Itself in Study after Study: A Brief Survey of Recent Literature

Centerline

When a new treatment technology comes on the scene, clinicians naturally want to be assured that it meets or exceeds the performance of established and familiar ones. Since HyperArc® high-definition radiotherapy was introduced at ASTRO in 2016, at least 8...

更多資訊

HyperArc Helps Community-Based Hospital Radiosurgery Program Succeed in a Highly Competitive Market

Centerline

Varian’s HyperArc® high-definition radiosurgery, delivered on the Edge® platform, is helping the radiosurgery program at Good Samaritan, a 408-bed community hospital in West Islip, NY, succeed in the highly competitive New York City (NYC) area market.

更多資訊

Is Prostate SBRT a Valid Option? The Evidence is In, and It's Good News

Centerline

After decades of data collected on thousands of patients, evidence points to SBRT as a safe and effective option for the treatment of early- to mid-stage prostate cancer.

更多資訊